MMJ Group Holdings Ltd Stock Market Press Releases and Company Profile
MediPharm Signs Customer Contracts Ahead of TSX-V Listing
MediPharm Signs Customer Contracts Ahead of TSX-V Listing

Perth, Sep 5, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (googlechartASX:MMJ) (googlechartMMJJF:OTCMKTS) ("MMJ") is pleased to note the attached three news releases by MediPharm Labs Inc ("MediPharm") providing the details of three customer contracts signed over the past month or so and ahead of its listing on the TSX Venture Exchange ("TSX-V") expected later this month.

MMJ's CEO Jason Conroy said that "We are delighted to see the momentum building for MediPharm ahead of its listing on the TSX-V."

MMJ owns approximately 6.9% of MediPharm.

To view the news releases, please visit:
http://abnnewswire.net/lnk/40E584H4


About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/

https://plus.google.com/112611716213432048650/posts https://www.youtube.com/channel/UCkDxKKC_fe2TdZfeVSpPVhw abnnewswire.com 


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 9) (Last 30 Days: 34) (Since Published: 5758)